BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36056728)

  • 1. Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor Expression.
    Williams M; Capcha JMC; Irion CI; Seo G; Lambert G; Kamiar A; Yousefi K; Kanashiro-Takeuchi R; Takeuchi L; Saad AG; Mendez A; Webster KA; Goldberger JJ; Hare JM; Shehadeh LA
    J Am Heart Assoc; 2022 Sep; 11(17):e027216. PubMed ID: 36056728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction.
    Williams M; Kamiar A; Condor Capcha JM; Rasmussen MA; Alitter Q; Kanashiro Takeuchi R; Mitsuru Takeuchi L; Hare JM; Shehadeh LA
    J Vis Exp; 2024 Mar; (205):. PubMed ID: 38619239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
    Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction.
    Hieda M; Sarma S; Hearon CM; MacNamara JP; Dias KA; Samels M; Palmer D; Livingston S; Morris M; Levine BD
    Circulation; 2021 Sep; 144(12):934-946. PubMed ID: 34543068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise training worsens cardiac performance in males but does not change ejection fraction and improves hypertrophy in females in a mouse model of metabolic syndrome.
    Tóth ME; Sárközy M; Szűcs G; Dukay B; Hajdu P; Zvara Á; Puskás LG; Szebeni GJ; Ruppert Z; Csonka C; Kovács F; Kriston A; Horváth P; Kővári B; Cserni G; Csont T; Sántha M
    Biol Sex Differ; 2022 Jan; 13(1):5. PubMed ID: 35101146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
    Satoh T; Wang L; Espinosa-Diez C; Wang B; Hahn SA; Noda K; Rochon ER; Dent MR; Levine AR; Baust JJ; Wyman S; Wu YL; Triantafyllou GA; Tang Y; Reynolds M; Shiva S; Hilaire CS; Gomez D; Goncharov DA; Goncharova EA; Chan SY; Straub AC; Lai YC; McTiernan CF; Gladwin MT
    Circulation; 2021 Aug; 144(8):615-637. PubMed ID: 34157861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
    Schwarzl M; Hamdani N; Seiler S; Alogna A; Manninger M; Reilly S; Zirngast B; Kirsch A; Steendijk P; Verderber J; Zweiker D; Eller P; Höfler G; Schauer S; Eller K; Maechler H; Pieske BM; Linke WA; Casadei B; Post H
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1407-18. PubMed ID: 26342070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".
    Mohammed SF; Ohtani T; Korinek J; Lam CS; Larsen K; Simari RD; Valencik ML; Burnett JC; Redfield MM
    Circulation; 2010 Jul; 122(4):370-8. PubMed ID: 20625113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of Na
    Primessnig U; Bracic T; Levijoki J; Otsomaa L; Pollesello P; Falcke M; Pieske B; Heinzel FR
    Eur J Heart Fail; 2019 Dec; 21(12):1543-1552. PubMed ID: 31762174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction.
    Gurwitz JH; Magid DJ; Smith DH; Goldberg RJ; McManus DD; Allen LA; Saczynski JS; Thorp ML; Hsu G; Sung SH; Go AS
    Am J Med; 2013 May; 126(5):393-400. PubMed ID: 23499328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
    Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
    Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.
    Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE
    Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis.
    Bouthoorn S; Valstar GB; Gohar A; den Ruijter HM; Reitsma HB; Hoes AW; Rutten FH
    Diab Vasc Dis Res; 2018 Nov; 15(6):477-493. PubMed ID: 30037278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction.
    Pilz PM; Ward JE; Chang WT; Kiss A; Bateh E; Jha A; Fisch S; Podesser BK; Liao R
    Circ Res; 2022 Jun; 130(12):1888-1905. PubMed ID: 35679365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.